Russia expects Gamaleya coronavirus vaccine to be registered in August

Moscow, Russia: Russia's first potential COVID-19 vaccine will win local regulatory approval in August, Russia's Deputy Prime Minister said during the online meeting with Putin on Wednesday, July 29, 2020.

The production of the vaccine developed by Gamaleya Centre would begin in September, Golikova said. A state research facility in Moscow - the Gamaleya Institute - completed early human trials of the adenovirus-based vaccine this month and expects to begin large-scale trials in August. The vaccine will win regulatory approval from authorities in Russia while that large-scale trial continues, Golikova said.

The speed at which Russia is moving to roll out the vaccine has prompted some Western media to question whether Moscow is putting national prestige before solid science and safety. More than 100 possible vaccines are being developed around the world to try to stop the COVID-19 pandemic. At least four are in final Phase III human trials, according to WHO data, including three developed in China and another in Britain.